Paul is a research Scientist in the Department of Computational Biomedicine at Cedars Sinai Medical Center, Los Angeles.

He qualified in medicine from the University of Oxford in 1986.  After a series of posts in internal medicine he worked for a year in Malawi on a leprosy vaccine trial. Paul then completed his training in public health medicine before taking up a post as research fellow in the CRC Human Cancer Genetics group at the University of Cambridge in 1996.  Having completed his doctoral studies in 1999 Paul won a Cancer Research UK Senior Clinical Research Fellowship.  On completion of the fellowship in 2009 he was appointed Reader in Cancer Epidemiology and promoted to a personal Chair in 2012, Department of Public Health and Primary Care, University of Cambridge.  He moved to Los Angeles in November 2022.

Paul’s major research interests are i) common genetic variation and breast and ovarian cancer susceptibility ii) the role of germline genotype in determining the clinical and molecular pathological characteristics of breast and ovarian cancer.

Paul has published over 600 papers reporting original research as well as numerous book chapters and review articles.